# Syros Pharmaceuticals Inc. (SYRS)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $0.00 (-50.00%)

> Syros Pharmaceuticals Inc. is a biopharmaceutical company that focuses on discovering and developing medicines to control the expression of genes with the goal of treating diseases. The primary function of Syros Pharmaceuticals is to leverage its proprietary platform to identify and target gene regulatory regions to create therapeutics for cancer and other challenging diseases. Key features of the company include its emphasis on precision medicine, using gene regulatory analysis to pioneer drug discovery and development. Syros Pharmaceuticals plays a crucial role in the biotechnology sector by expanding treatment options for conditions that are currently underserved by existing therapies. Its innovative approach is redefining how genetic medicine can be applied to modern healthcare problems. Based in Cambridge, Massachusetts, Syros aims to produce novel therapeutics that address the underlying causes of disease, offering hope for patients through its groundbreaking scientific research and development.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/SYRS)